SpringWorks Therapeutics, Inc.
SpringWorks Therapeutics, Inc. (SWTX) Stock Forecast & Analyst Price Target
Wall Street consensus, 12-month price targets, model projections, and EPS/revenue estimates — from analyst data and price history.
swtx · stock forecast · 11 analysts (3M) · FMP · updated Oct 9, 2025
Analyst Rating & Consensus
Based on 11 Wall Street analysts in the past 3 months
Buy
11 analysts
consensus
Rating Breakdown
12-Month Price Target
High
$78.00
Consensus
$65.40
+39.2% upside
Low
$47.00
Median: $76 · Last Close: $46.99
12-Month Price Target Forecast
Historical closing prices + analyst 12-month price target forecast cone
Consensus Target
$65.40
39.2% upside
High Target
$78
66.0%
Low Target
$47
0.0%
Current Price
$46.99
as of today
Based on analyst price targets, the SWTX stock price prediction for the next 12 months ranges from $47 to $78. The consensus SWTX price forecast of $65.40 implies 39.2% upside from the current price of $46.99.
Short-Term Price Prediction
BullAlgorithmically generated · Updated daily
| Date | Predicted Price | Change |
|---|---|---|
| 2026-06-10 | $46.98 | ↓ 0.03% |
1-day model range: $46.96–$46.99. Peak: $46.99 (-0.03%).
Long-Term Stock Price Prediction
Annual stock price forecast · 2027 / 2028 / 2029 / 2030 / 2031
| Year | Avg Price | Change |
|---|---|---|
| 2027 | $56 | +18.7% |
| 2028 | $62 | +32.0% |
| 2029 | $66 | +40.9% |
| 2030 | $69 | +46.6% |
| 2031 | — | +50.1% |
Stock Forecast Based on Technical Analysis
14 TA signals (SMA×6 + EMA×6 + RSI + MACD) · EEAT method transparency
Market Sentiment
BULLISH
Based on 14 technical indicators
Refreshes daily from EOD close
Moving Averages · SWTX · Jun 9, 2026
Latest Analyst Ratings & Upgrades
| Date | Brokerage | Action | Rating |
|---|---|---|---|
| 2025-05-12 | Guggenheim | Maintains | Neutral→Neutral |
| 2025-04-30 | HC Wainwright & Co. | Downgrade ↓ | Buy→Neutral |
| 2025-04-29 | TD Cowen | Downgrade ↓ | Buy→Hold |
| 2025-04-29 | Guggenheim | Downgrade ↓ | Buy→Neutral |
| 2025-04-28 | Barclays | Downgrade ↓ | Overweight→Equal Weight |
| 2025-02-24 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-21 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-12 | HC Wainwright & Co. | Maintains | Buy→Buy |
| 2025-02-12 | Evercore ISI Group | Maintains | Outperform→Outperform |
| 2025-02-12 | Wedbush | Maintains | Outperform→Outperform |
Wall Street analysts have recently issued updated ratings on SpringWorks Therapeutics, Inc. (SWTX) stock. Of the recent 70 rating actions, 2 were upgrades and 6 were downgrades. 11 analysts currently cover SWTX.
Analyst Recommendation Trends
SWTX analyst recommendation trends show decreasing buy-side sentiment over the past 6 months. Buy rating actions changed from 1 to 0 per month.
Financial Forecast: EPS & Revenue Estimates
Revenue This Year
$335M
↓ 60.1% YoY
Revenue Next Year
$612M
↑ 82.8% YoY
EPS This Year
$-2.75
EPS Next Year
$-0.83
↓ 70.0% YoY
EPS ForecastReported vs Estimated
Analysts forecast SWTX EPS of $-2.75 for the current fiscal year, based on estimates from 3 analysts. The SWTX revenue forecast is $335M for the current year. These are analyst consensus estimates via FMP / S&P Global.
About Forecast & Price Prediction
The SWTX stock forecast is supported by two independent data sources: analyst consensus ratings from 11 Wall Street analysts (S&P Global / FMP), and technical analysis calculated from historical EOD price data. The consensus SWTX price target is $65.40 (+39.2% upside), with an analyst consensus of Buy.
The SWTX short-term stock prediction for tomorrow is $46.98 (-0.03%). The SWTX stock price prediction for 2027 estimates an average of $56. The SWTX stock prediction for 2030 projects a range of $69–$69.
SpringWorks Therapeutics, Inc. trades on NASDAQ under the ticker SWTX. The SWTX stock outlook for 2027 is broadly positive, supported by a Buy consensus among 64% of covering analysts.
Frequently asked questions
SWTX forecast · 8 questionsAccording to 11 Wall Street analysts, the average 12-month SWTX price target is $65.40, with a high forecast of $78.00 and a low of $47.00. The median price target is shown in the chart above when available. This implies +39.2% potential upside from the current price of $46.99.
· Analyst data: Financial Modeling Prep (FMP) · S&P Global Market Intelligence · Technical analysis: FMP /historical-price-eod/light · Updated: Hourly (analyst) · Daily (technical)
⚠ This information is provided for informational purposes only and does not constitute investment advice. Short-term and long-term price predictions are algorithmically generated and carry significant uncertainty. Past performance does not guarantee future results. Always conduct your own due diligence before making investment decisions.